(Q45004422)

8 December 2017

Population pharmacokinetic analysis of mirtazapine (English)

1 reference

8 December 2017

1 reference

8

Marcella Rietschel

1 reference

8 December 2017

7

Christoph Hiemke

1 reference

8 December 2017

Katja Grasmäder

1

1 reference

8 December 2017

Petra Louise Verwohlt

2

1 reference

8 December 2017

Kai-Uwe Kühn

3

1 reference

8 December 2017

Aleksandra Dragicevic

4

1 reference

8 December 2017

Olrik von Widdern

5

1 reference

8 December 2017

Astrid Zobel

6

1 reference

8 December 2017

Wolfgang Maier

9

1 reference

8 December 2017

Ulrich Jaehde

10

1 reference

8 December 2017

Marie Luise Rao

11

1 reference

8 December 2017

1 September 2004

1 reference

European Journal of Clinical Pharmacology

8 December 2017

1 reference

8 December 2017

60

1 reference

8 December 2017

7

1 reference

8 December 2017

473-480

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-004-0737-0

8 December 2017

0 references

cites work

A double-blind study comparing the efficacy and tolerability of mirtazapine and doxepin in patients with major depression

1 reference

12 December 2020

[Therapeutic drug monitoring of antidepressives--therapeutic and health economics advantages]

1 reference

12 December 2020

Clinical pharmacokinetics of mirtazapine

1 reference

12 December 2020

An efficient strategy for detection of known and new mutations of the CYP2D6 gene using single strand conformation polymorphism analysis

1 reference

12 December 2020

Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology

1 reference

12 December 2020

Double-blind study of mirtazapine and placebo in hospitalized patients with major depression

1 reference

12 December 2020

Phenotyping of CYP2C19 with enantiospecific HPLC-quantification of R- and S-mephenytoin and comparison with the intron4/exon5 G-->A-splice site mutation.

1 reference

12 December 2020

Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4

1 reference

12 December 2020

Elucidation of the genetic basis of the common 'intermediate metabolizer' phenotype for drug oxidation by CYP2D6

1 reference

12 December 2020

Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder

1 reference

12 December 2020

A new method for quick estimation of the absorption rate constant for clinical purposes using a nomograph.

1 reference

12 December 2020

A risk-benefit assessment of mirtazapine in the treatment of depression

1 reference

12 December 2020

Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment.

1 reference

12 December 2020

A double-blind placebo-controlled study of Org 3770 in depressed outpatients

1 reference

12 December 2020

Pharmacokinetics and biotransformation of mirtazapine in human volunteers

1 reference

12 December 2020

Allelic, genotypic and phenotypic distributions of S-mephenytoin 4'-hydroxylase (CYP2C19) in healthy Caucasian populations of European descent throughout the world

1 reference

12 December 2020

Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects

1 reference

12 December 2020

Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population

1 reference

12 December 2020

Ultrarapid metabolizers of debrisoquine: Characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene

1 reference

12 December 2020

A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression

1 reference

12 December 2020

Fluvoxamine augmentation increases serum mirtazapine concentrations three- to fourfold

1 reference

12 December 2020

The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans

1 reference

12 December 2020

A multicentre, double-blind, amitriptyline-controlled study of mirtazapine in patients with major depression

1 reference

12 December 2020

10.1007/S00228-004-0737-0

Identifiers

DOI

1 reference

Dimensions Publication ID

8 December 2017

0 references

1 reference